Yahoo Poland Wyszukiwanie w Internecie

Search results

1. finance.yahoo.com › news › fusion-pharmaceuticals-acquired-astrazenecaFusion Pharmaceuticals to be Acquired by AstraZeneca,...

   finance.yahoo.com › news › fusion-pharmaceuticals-acquired-astrazeneca

   • Zapisane w pamięci cache

   19 mar 2024 · Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced the Company has...

   • FusionPharm, Inc. (FSPM) Latest Stock News & Headlines - Yahoo Finance

     Get the latest FusionPharm, Inc. (FSPM) stock news and...

2. www.astrazeneca.com › media-centre › press-releasesAcquisition of Fusion completed - AstraZeneca

   www.astrazeneca.com › media-centre › press-releases

   • Zapisane w pamięci cache

   4 cze 2024 · AstraZeneca today announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).

3. finance.yahoo.com › quote › FSPMFusionPharm, Inc. (FSPM) Latest Stock News & Headlines - Yahoo...

   finance.yahoo.com › quote › FSPM

   • Zapisane w pamięci cache

   Get the latest FusionPharm, Inc. (FSPM) stock news and headlines to help you in your trading and investing decisions.

4. www.astrazeneca.com › press-releases › 2024AstraZeneca to acquire Fusion to accelerate the development of...

   www.astrazeneca.com › press-releases › 2024

   • Zapisane w pamięci cache

   19 mar 2024 · AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).

5. www.prnewswire.com › news-releases › fusion-pharmaceuticals-to-be-acquired-by-astFusion Pharmaceuticals to be Acquired by AstraZeneca,...

   www.prnewswire.com › news-releases › fusion-pharmaceuticals-to-be-acquired-by-ast

   • Zapisane w pamięci cache

   19 mar 2024 · Transaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities.

6. www.reuters.com › markets › dealsAstraZeneca bets on next-generation cancer therapy with $2 bln...

   www.reuters.com › markets › deals

   19 mar 2024 · AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals Inc for $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments.

7. finance.yahoo.com › news › fusion-pharmaceuticals-shareholders-approve-acquisitionFusion Pharmaceuticals Shareholders Approve Acquisition by...

   finance.yahoo.com › news › fusion-pharmaceuticals-shareholders-approve-acquisition

   • Zapisane w pamięci cache

   29 maj 2024 · Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced that at a...